These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22116824)
1. A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. Alli R; Nguyen P; Boyd K; Sundberg JP; Geiger TL J Immunol; 2012 Jan; 188(1):477-86. PubMed ID: 22116824 [TBL] [Abstract][Full Text] [Related]
2. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction. Gao Z; Jin YQ; Wu W Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620 [TBL] [Abstract][Full Text] [Related]
5. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819 [TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Gilhar A; Kalish RS Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213 [TBL] [Abstract][Full Text] [Related]
7. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss. Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100 [TBL] [Abstract][Full Text] [Related]
9. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Zhang JG; Oliver RF Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477 [TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. Nakamura M; Jo J; Tabata Y; Ishikawa O Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811 [TBL] [Abstract][Full Text] [Related]
11. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017 [TBL] [Abstract][Full Text] [Related]
12. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model. Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266 [TBL] [Abstract][Full Text] [Related]
13. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. McElwee KJ; Spiers EM; Oliver RF Br J Dermatol; 1999 Mar; 140(3):432-7. PubMed ID: 10233262 [TBL] [Abstract][Full Text] [Related]
14. [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease]. Freyschmidt-Paul P; Happle R; Hoffmann R Hautarzt; 2003 Aug; 54(8):713-22. PubMed ID: 12942185 [TBL] [Abstract][Full Text] [Related]
15. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166 [TBL] [Abstract][Full Text] [Related]
16. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862 [TBL] [Abstract][Full Text] [Related]
17. Toward the Clonotype Analysis of Alopecia Areata-Specific, Intralesional Human CD8+ T Lymphocytes. Bertolini M; Uchida Y; Paus R J Investig Dermatol Symp Proc; 2015 Nov; 17(2):9-12. PubMed ID: 26551936 [TBL] [Abstract][Full Text] [Related]
18. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. Bertolini M; Zilio F; Rossi A; Kleditzsch P; Emelianov VE; Gilhar A; Keren A; Meyer KC; Wang E; Funk W; McElwee K; Paus R PLoS One; 2014; 9(5):e94260. PubMed ID: 24832234 [TBL] [Abstract][Full Text] [Related]
20. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. Ito T; Ito N; Saatoff M; Hashizume H; Fukamizu H; Nickoloff BJ; Takigawa M; Paus R J Invest Dermatol; 2008 May; 128(5):1196-206. PubMed ID: 18160967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]